The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multimodality therapy for borderline resectable pancreatic cancer: A single-institution experience.
Jose Mario Pimiento
No relevant relationships to disclose
Tai Hutchinson
No relevant relationships to disclose
Jill M. Weber
No relevant relationships to disclose
Manish R. Patel
No relevant relationships to disclose
Pamela Joy Hodul
No relevant relationships to disclose
Michael D. Chuong
No relevant relationships to disclose
Gregory M. Springett
No relevant relationships to disclose
Sarah E. Hoffe
No relevant relationships to disclose
Richard C. Karl
No relevant relationships to disclose
Barbara Centeno
No relevant relationships to disclose
Jason Klapman
No relevant relationships to disclose
Ravi Shridhar
No relevant relationships to disclose
Dung-Tsa Chen
No relevant relationships to disclose
Mokenge Peter Malafa
No relevant relationships to disclose